Head-to-head · WeighScore
Roboclinic vs Strut Health
By GLP-1 ScorecardUpdated
Score comparison
Strut Health has the higher recorded score — 79.4/100 to 65.3/100.
Strut Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Four compounded offers with separate oral and injectable prices; semaglutide's conflicting oral prices and dose-related costs need a selected prescription quote.
Before you choose
Roboclinic does not publish a semaglutide price, so its Roboclinic review sets out what it does disclose, while the Strut Health review explains the conditions attached to Strut Health's figure. The semaglutide cost page compares published rates across the field. Ask Roboclinic for a written total before treating either one as the cheaper choice.
If neither one fits, Roboclinic vs telos rx and SkinnyRx vs Strut Health compare each of them with another graded program, and the list of alternatives to Roboclinic ranks the programs closest to Roboclinic on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Roboclinic | Strut Health |
|---|---|---|
| WeighScore | 65.3/100 | 79.4/100 |
| Grade | C | C+ |
| Site position | #242 | #26 |
| Semaglutide | Confirm selected price and renewal terms | Oral from $99/30 days; injection from $129/mo; oral page conflicts at $199—confirm dose and renewal |
| Tirzepatide | Confirm selected price and renewal terms | Oral $199/30 days; injection from $149/mo depending on prescribed dose—confirm quantity and renewal |
| Coverage | Coverage not published | FAQ says all states except Arkansas as of September 2024; confirm current medication and route eligibility |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Yes | Yes |
Strengths
- Lists semaglutide injections and tablets separately
- Names OpenLoop Health as its clinical and fulfillment coordinator
What to consider
- Public price cards reference extended plans without establishing the selected commitment and renewal
- The platform refund policy covers several types of subscriptions, including chat features
FDAWarning letter issued to Strut Health, LLC dba Strut in February 2026. See the FDA warning-letter database.
Strengths
- Dedicated pages list separate oral and injectable semaglutide and tirzepatide prices
- Provider consultations, follow-ups and shipping are advertised as included
- Current help describes an account cancellation button; terms also provide an email route
- Tirzepatide pages advertise flat pricing across strengths, subject to confirmation for the selected prescription
What to consider
- Dedicated oral semaglutide page lists $99 while the general semaglutide page lists oral $199; help warns dose increases raise price
- Product pages describe buccal semaglutide while dose help describes sublingual use; exact formula and instructions need confirmation
- 48-hour cancellation descriptions differ between shipment and processing; processed prescriptions are not refundable
- Assigned GLP-1 pharmacy and a required or included lab program were not established; the general state footprint is dated September 2024
Featured provider
Strut Health
Factor scores not reassessed.Strut Health scores 79.4/100 (C+). Four compounded offers with separate oral and injectable prices; semaglutide's conflicting oral prices and dose-related costs need a selected prescription quote.
Commercial relationships affect this placement. The score comparison above is separate.
FDAWarning letter issued to Strut Health, LLC dba Strut in February 2026. See the FDA warning-letter database.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.